@vanessadaniel.bsky.social
#Ravidasvir was a medical milestone for Malaysia.
It shows what people-centric partnerships and political will can achieve.
As Dato' Dr Radzi said, South-South cooperation is a model for #innovation in the Global South.
At DNDi, the work continues. Affordability and access remain our focus.
It shows what people-centric partnerships and political will can achieve.
As Dato' Dr Radzi said, South-South cooperation is a model for #innovation in the Global South.
At DNDi, the work continues. Affordability and access remain our focus.
Developing Countries Can Lead in Medical Innovation | by Muhammad Radzi Abu Hassan - Project Syndicate
Muhammad Radzi Abu Hassan shows how regional collaboration and targeted investment can improve access to therapeutics and diagnostics.
www.project-syndicate.org
April 24, 2025 at 3:27 AM
#Ravidasvir was a medical milestone for Malaysia.
It shows what people-centric partnerships and political will can achieve.
As Dato' Dr Radzi said, South-South cooperation is a model for #innovation in the Global South.
At DNDi, the work continues. Affordability and access remain our focus.
It shows what people-centric partnerships and political will can achieve.
As Dato' Dr Radzi said, South-South cooperation is a model for #innovation in the Global South.
At DNDi, the work continues. Affordability and access remain our focus.
Wishing all those celebrating a wonderful Songkran Festival.
May this Thai New Year bring you and your loved ones joy and prosperity.
May this Thai New Year bring you and your loved ones joy and prosperity.
April 15, 2025 at 4:07 AM
Wishing all those celebrating a wonderful Songkran Festival.
May this Thai New Year bring you and your loved ones joy and prosperity.
May this Thai New Year bring you and your loved ones joy and prosperity.
This! #DNDi’s Hepatitis C work in Malaysia is a great example of what open science can do in real life: affordable, effective treatment, developed through collaboration and tested where it’s most needed. Ravidasvir + sofosbuvir is proof that drug development doesn’t have to follow the status quo.
Did you know that we can manage patents in a way that serves the public good?
Our Intellectual Property & Access Leader shares why, together with our partners from the @asapdiscovery.bsky.social, we are filing a #patent for a promising new #molecule that we developed together.
shorturl.at/IgL80
Our Intellectual Property & Access Leader shares why, together with our partners from the @asapdiscovery.bsky.social, we are filing a #patent for a promising new #molecule that we developed together.
shorturl.at/IgL80
How patents can serve the common good
YouTube video by Drugs for Neglected Diseases initiative (DNDi)
youtube.com
April 11, 2025 at 3:29 AM
This! #DNDi’s Hepatitis C work in Malaysia is a great example of what open science can do in real life: affordable, effective treatment, developed through collaboration and tested where it’s most needed. Ravidasvir + sofosbuvir is proof that drug development doesn’t have to follow the status quo.
Klang now has 5 #Dengue hotspots—21 across Malaysia. With climate change, outbreaks are rising. The #DengueAlliance is developing affordable therapeutics to protect pregnant women, kids & high-risk groups—uniting global partners to stop severe dengue.
April 10, 2025 at 5:37 AM
Klang now has 5 #Dengue hotspots—21 across Malaysia. With climate change, outbreaks are rising. The #DengueAlliance is developing affordable therapeutics to protect pregnant women, kids & high-risk groups—uniting global partners to stop severe dengue.
The most neglected, vulnerable, and marginalized communities are bearing and will continue to bear the brunt of these decisions’
DNDi statement on recent US government executive actions and the escalating retreat from global health and medical research ⤵️
bit.ly/4hAAoFy
bit.ly/4hAAoFy
DNDi statement on recent US government executive actions and the escalating retreat from global health and medical research
As an international non-profit organization that discovers, develops, and delivers treatments for neglected communities, the Drugs for Neglected Diseases initiative (DNDi) expresses its alarm at drast...
bit.ly
February 14, 2025 at 12:37 AM
The most neglected, vulnerable, and marginalized communities are bearing and will continue to bear the brunt of these decisions’
We co-hosted a side event at the Prince Mahidol Award Conference. The panel discussion on South-South collaboration against #NTDs was quite engaging.
Political will, strategic partnerships & scientific evidence are key to address public health threats like #HepC, #dengue.
@dndi.org
Political will, strategic partnerships & scientific evidence are key to address public health threats like #HepC, #dengue.
@dndi.org
January 31, 2025 at 3:00 AM
A recent meeting in Bangkok between @dndi.org, Pharco Corporation Egypt, Government Pharmaceutical Organisation (GPO) & Mahidol University discussed HepC patients’ limited access to Ravidasvir. Thank you GPO & Assoc Prof Surakit for hosting. Ravidasvir will improve the lives of 2M people in Thailand
January 29, 2025 at 4:34 AM
A recent meeting in Bangkok between @dndi.org, Pharco Corporation Egypt, Government Pharmaceutical Organisation (GPO) & Mahidol University discussed HepC patients’ limited access to Ravidasvir. Thank you GPO & Assoc Prof Surakit for hosting. Ravidasvir will improve the lives of 2M people in Thailand
Honored to host Dato' Wira Dr. Muhammad Radzi bin Abu Hassan, DG of MoH Malaysia, at @dndi.org
We discussed:
🩺 Expanding hepatitis C access to neglected patients across SEA
🦟 Dengue R&D collab in clinical trials
💊 Urgent need for LAMB formulations
We’re driving real change together!
We discussed:
🩺 Expanding hepatitis C access to neglected patients across SEA
🦟 Dengue R&D collab in clinical trials
💊 Urgent need for LAMB formulations
We’re driving real change together!
November 29, 2024 at 9:05 AM
Honored to host Dato' Wira Dr. Muhammad Radzi bin Abu Hassan, DG of MoH Malaysia, at @dndi.org
We discussed:
🩺 Expanding hepatitis C access to neglected patients across SEA
🦟 Dengue R&D collab in clinical trials
💊 Urgent need for LAMB formulations
We’re driving real change together!
We discussed:
🩺 Expanding hepatitis C access to neglected patients across SEA
🦟 Dengue R&D collab in clinical trials
💊 Urgent need for LAMB formulations
We’re driving real change together!